Vaginal trichomoniasis: Clinical sciences

Last updated: January 30, 2025

Vaginal trichomoniasis: Clinical sciences

MPAN 690 Week 1 - Obstetrics & Gynecology

MPAN 690 Week 1 - Obstetrics & Gynecology

Anatomy of the breast
Anatomy clinical correlates: Breast
Approach to a breast mass and asymmetry: Clinical sciences
Benign breast conditions: Pathology review
Fibrocystic breast changes
Fibrocystic breast changes: Clinical sciences
Breast papilloma: Clinical sciences
Fibroadenoma: Clinical sciences
Breast cyst: Clinical sciences
Approach to nipple discharge: Clinical sciences
Approach to breast pain (mastalgia): Clinical sciences
Mastitis: Clinical sciences
Breast abscess: Clinical sciences
Breast cancer
Breast cancer screening: Clinical sciences
Breast cancer: Pathology review
Ductal carcinoma in situ: Clinical sciences
Invasive ductal carcinoma: Clinical sciences
Lobular carcinoma in situ: Clinical sciences
Invasive lobular carcinoma: Clinical sciences
Inflammatory breast cancer: Clinical sciences
Paget disease of the breast
Well-patient care (GYN): Clinical sciences
Cervix and vagina histology
Cervical cancer
Cervical cancer screening: Clinical sciences
Cervical dysplasia and cervical cancer: Clinical sciences
Cervical cancer: Pathology review
Vulvar dysplasia and vulvar cancer: Clinical sciences
Approach to vaginal discharge: Clinical sciences
Sexually transmitted infection screening (GYN): Clinical sciences
Sexually transmitted infection screening (Family medicine): Clinical sciences
Sexually transmitted infections: Vaginitis and cervicitis: Pathology review
Candida
Vulvovaginal candidiasis: Clinical sciences
Gardnerella vaginalis (Bacterial vaginosis)
Bacterial vaginosis: Clinical sciences
Trichomonas vaginalis
Vaginal trichomoniasis: Clinical sciences
Chlamydia trachomatis
Chlamydia trachomatis infection: Clinical sciences
Neisseria gonorrhoeae
Neisseria gonorrhoeae infection: Clinical sciences
Pelvic inflammatory disease
Pelvic inflammatory disease: Clinical sciences
Reversible contraception: Clinical sciences
Permanent contraception (sterilization): Clinical sciences
Emergency contraception: Clinical sciences
Approach to dysmenorrhea: Clinical sciences
Primary dysmenorrhea: Clinical sciences
Approach to abnormal uterine bleeding in reproductive-aged patients: Clinical sciences
Approach to acute pelvic pain (GYN): Clinical sciences
Approach to chronic pelvic pain (GYN): Clinical sciences
Uterine disorders: Pathology review
Uterine fibroid
Stress, urge, overflow, and mixed urinary incontinence (GYN): Clinical sciences
Preconception care: Clinical sciences
Pregnancy
Ectopic pregnancy
Ectopic pregnancy: Clinical sciences
Complications during pregnancy: Pathology review
Anemia in pregnancy: Clinical sciences
Nausea and vomiting of pregnancy: Clinical sciences
Asthma in pregnancy: Clinical sciences
Cholestasis of pregnancy: Clinical sciences
Diabetes in pregnancy (GDM, T1DM, and T2DM): Clinical sciences
Approach to diabetes in pregnancy: Clinical sciences
Approach to hypertensive disorders in pregnancy: Clinical sciences
Chronic hypertension in pregnancy: Clinical sciences
Venous thromboembolism in pregnancy: Clinical sciences
Urinary tract infections and kidney stones in pregnancy: Clinical sciences
Group B streptococcus (GBS) colonization in pregnancy: Clinical sciences
Herpes simplex virus infection in pregnancy: Clinical sciences
Cytomegalovirus (CMV), parvovirus B19, varicella zoster, and toxoplasmosis infection in pregnancy: Clinical sciences
Alcohol, tobacco, cannabinoid, and substance use in pregnancy: Clinical sciences
Perinatal depression and anxiety: Clinical sciences
Hemoglobinopathies in pregnancy: Clinical sciences
Abdominal trauma in pregnancy: Clinical sciences
Early pregnancy loss: Clinical sciences
Miscarriage
Late-term and postterm pregnancy: Clinical sciences
Antepartum care (first trimester): Clinical sciences
Approach to first trimester bleeding: Clinical sciences
Antepartum care (second trimester): Clinical sciences
Antepartum care (third trimester): Clinical sciences
Approach to third trimester bleeding: Clinical sciences
Placenta previa and vasa previa: Clinical sciences
Placenta previa
Prelabor rupture of membranes: Clinical sciences
Preterm labor: Clinical sciences
Fetal growth restriction: Clinical sciences
Uterine stimulants and relaxants
Therapeutic and induced abortions: Clinical sciences
Menopause
Perimenopause, menopause, and primary ovarian insufficiency: Clinical sciences
Approach to postmenopausal bleeding: Clinical sciences

Decision-Making Tree

Transcript

Watch video only

Vaginal trichomoniasis is among the most prevalent sexually transmitted infections, or STIs, worldwide. It is caused by the protozoan parasite, Trichomonas vaginalis. Most patients infected with trichomonas have minimal or no symptoms, and untreated infections can last for months to years. Trichomonas infection is associated with an increased risk of both HIV acquisition and HIV shedding, and it increases the risk of pelvic inflammatory disease among HIV-positive patients. Additionally, it has been associated with an increased risk of cervical cancer. In pregnancy, trichomonas infection increases the risk of preterm birth, prelabor rupture of membranes and small for gestational age infants.

Your first step in evaluating a patient who presents with a chief concern suggesting vaginal trichomoniasis is obtaining a focused history and physical exam. This should include a sexual history, such as recent sexual activity or new partners, so be sure to have a private and confidential discussion. Although it might be difficult, you should ask caregivers of young patients to step out of the room for this discussion. Additionally, always consider sexual assault or abuse whenever a young patient has a positive sexual activity history, especially if the patient is a child. If there is abuse going on, you will need to follow up with allegations of abuse in accordance with your State’s law.

Now, keep in mind that trichomoniasis can be spread through vaginal fluids So some practices like sharing of sex toys can cause infection. In addition to sexual history, ask about hygiene practices, such as douching, which can remove some of the bacteria that make up the normal vaginal flora, increasing the risk of overgrowth of infectious pathogens. Although most patients are usually asymptomatic, some may report a malodorous vaginal discharge, vulvar pruritus or irritation, and dysuria.

Physical exam findings include a yellow frothy vaginal discharge; as well as vaginal or cervical erythema with petechiae, which is often referred to as a “strawberry cervix.” Based on these findings, you should suspect vaginal trichomoniasis.

Here is a high-yield fact! In the United States, the prevalence of vaginal trichomoniasis is almost 10 times higher among black patients than non-Hispanic white patients. Some additional risk factors for trichomonas infection include socioeconomic factors like incarceration, having less than a high school education, and poverty.

So, if you suspect vaginal trichomoniasis, let’s take a look at your next step to confirm the diagnosis. To do this, obtain samples of the vaginal discharge from the vaginal walls and fornices. Evaluate the discharge with saline microscopy, particularly looking for motile trichomonads, and assess the vaginal pH. In addition, you may perform nucleic acid amplification testing, or NAAT, for Trichomonas vaginalis. While NAAT testing is highly sensitive and detects more trichomonas infections, keep in mind that it’s more expensive and less timely than microscopy.

Okay, time for a couple of clinical pearls! First, vaginal cultures can be used to detect Trichomonas vaginalis, but these are rarely used, as NAAT testing has higher sensitivity and better detection rates. Additionally, there are also some FDA-approved rapid tests available for detecting Trichomonas vaginalis. Second, vaginal trichomoniasis has a high prevalence in patients with HIV infection, can increase viral shedding, and is strongly associated with pelvic inflammatory disease among these patients. For these reasons, yearly screening for trichomonas is recommended for patients with HIV infection.

Now let’s review our results. If there is an absence of trichomonads on saline microscopy, the vaginal pH is lower than or equal to 4.5, or a NAAT is negative for Trichomonas, consider an alternative diagnosis. However, keep in mind that time matters here, and sensitivity decreases quickly within 1 hour after specimen collection, so you should attempt to evaluate it immediately!

Sources

  1. "ACOG practice bulletin no. 215: Vaginitis in nonpregnant patients" Obstet Gynecol (2020)
  2. "Sexually transmitted infections treatment guidelines, 2021" MMWR Recomm Rep (2021)